Relay Therapeutics RLAY
$16.12 +$0.21 (+1.32%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $16.19 +0.46%
Open$15.59
Prev close$15.91
Day range$15.17 – $16.33
Volume3.98M
Market cap$3.56B
P/E (TTM)–
Dividend yield–
RLAY Stock News
Headlines matching Relay Therapeutics or the RLAY ticker, most recent first.
- JonesTrading Maintains Relay Therapeutics(RLAY.US) With Buy Rating, Maintains Target Price $20
- CCORF Maintains Relay Therapeutics(RLAY.US) With Buy Rating, Maintains Target Price $29
- Barclays Maintains Relay Therapeutics(RLAY.US) With Buy Rating, Raises Target Price to $30 Positive
- TD Cowen Maintains Relay Therapeutics(RLAY.US) With Buy Rating
- J.P. Morgan Maintains Relay Therapeutics(RLAY.US) With Buy Rating
- H.C. Wainwright Maintains Relay Therapeutics(RLAY.US) With Buy Rating, Maintains Target Price $29
- H.C. Wainwright Maintains Relay Therapeutics(RLAY.US) With Buy Rating, Raises Target Price to $29 Positive
- J.P. Morgan Maintains Relay Therapeutics(RLAY.US) With Buy Rating, Announces Target Price $31
- Citizens JMP Maintains Relay Therapeutics(RLAY.US) With Buy Rating, Raises Target Price to $26 Positive
- Goldman Sachs Maintains Relay Therapeutics(RLAY.US) With Buy Rating, Raises Target Price to $31 Positive
- CCORF Initiates Relay Therapeutics(RLAY.US) With Buy Rating, Announces Target Price $29
- Goldman Sachs Maintains Relay Therapeutics(RLAY.US) With Buy Rating, Maintains Target Price $22
- Analysts Are Bullish on These Healthcare Stocks: BrightSpring Health Services, Inc. (BTSG), Relay Therapeutics (RLAY) Positive
- Oppenheimer Maintains Relay Therapeutics(RLAY.US) With Buy Rating, Maintains Target Price $18
- A Quick Look at Today's Ratings for Relay Therapeutics(RLAY.US), With a Forecast Between $18 to $21
No comments yet — be the first to weigh in on RLAY.
Sign in to join the discussion.